Publication Name	World Journal of Hepatology
Manuscript ID	30000
Country	Italy

Received	2016-09-03 09:36
Peer-Review Started	2016-09-03 20:06
To Make the First Decision	2016-10-20 09:20
Return for Revision	2016-10-24 15:14
Revised	2016-10-26 00:33
Second Decision	2016-11-10 14:26
Accepted by Journal Editor-in-Chief	2016-11-10 17:39
Accepted by Company Editor-in-Chief	2016-12-02 10:37
Articles in Press	2016-12-02 10:37
Publication Fee Transferred
Edit the Manuscript by Language Editor	2016-12-15 05:58
Typeset the Manuscript	2017-03-01 12:39
Publish the Manuscript Online	2017-03-06 15:54

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C
Manuscript Source	Invited Manuscript
All Author List	Francesca Romana Ponziani, Francesca Mangiola, Cecilia Binda, Maria Assunta Zocco, Massimo Siciliano, Antonio Grieco, Gian Lodovico Rapaccini, Maurizio Pompili and Antonio Gasbarrini
Funding Agency and Grant Number
Corresponding Author	Cecilia Binda, MD, Internal Medicine, Gastroenterology and Hepatology, Catholic University Sacred Heart of Rome, Agostino Gemelli Hospital, Largo Agostino Gemelli 8, 00168 Rome, Italy. cecilia.binda@gmail.com
Key Words	Direct acting antivirals; Hepatitis C; Liver transplantation; Liver fibrosis; Cirrhosis; Hepatocellular carcinoma
Core Tip	The approval of new direct acting antivirals with high rates of virological clearance and excellent tolerability has dramatically improved hepatitis C virus (HCV) infection curability, especially for patients with advanced liver disease and for liver transplant recipients. The aim of this review is to draw the possible future scenery in HCV-related liver disease, focusing our attention on the impact of second generation direct acting antivirals on liver fibrosis, hepatocellular carcinoma and liver transplantation.
Publish Date	2017-03-06 15:54
Citation	Ponziani FR, Mangiola F, Binda C, Zocco MA, Siciliano M, Grieco A, Rapaccini GL, Pompili M, Gasbarrini A. Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C. World J Hepatol 2017; 9(7): 352-367
URL	http://www.wjgnet.com/1948-5182/full/v9/i7/352.htm
DOI	http://dx.doi.org/10.4254/wjh.v9.i7.352

Full Article (PDF)	WJH-9-352.pdf
Full Article (Word)	WJH-9-352.doc
Manuscript File	30000-Review.docx
Answering Reviewers	30000-Answering reviewers.pdf
Audio Core Tip	30000-Audio core tip.aiff
Conflict-of-Interest Disclosure Form	30000-Conflict-of-interest statement.pdf
Copyright License Agreement	30000-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	30000-Language certificate.pdf
Peer-review Report	30000-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	30000-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	30000-Scientific misconduct check.pdf
Scientific Editor Work List	30000-Scientific editor work list.pdf